Sherlock Biosciences Raises $80 Million In Series B Financing To Democratize At-Home Diagnostic Testing
Amount Raised
$80 Million
Round Type
Series B
BostonBiotechnologyHealthcareData And AnalyticsHealth CareScience And EngineeringDescription
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced it has raised $80 million in a Series B financing. The round was led by Novalis LifeSciences and included new investors Illumina Ventures, Albany Capital and Catalio Capital Management, among others. They joined Northpond Ventures, Good Ventures, and other existing investors, bringing $111 million in total funding raised to date.
Quick answer
Sherlock Biosciences raised $80 Million in a Series B round, dated March 8, 2022. Sherlock Biosciences is based in Boston, Massachusetts, United States.
- How much did Sherlock Biosciences raise?
- Sherlock Biosciences raised $80 Million in a Series B round on March 8, 2022.
- What does Sherlock Biosciences do?
- Sherlock Biosciences is developing products that will empower people to access answers and have more control over their health decisions.
- Where is Sherlock Biosciences based and how big is it?
- Sherlock Biosciences is based in Boston, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Data And Analytics around the same time
Companies in the same sectors as Sherlock Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Unlearn raised $50M (Series B) on April 19, 2022.
- Unlearn raised $50M on April 19, 2022.
- Ensem Therapeutics raised $67M (Series A) on April 6, 2022.
- Clarify Health raised $150M (Series D) on April 5, 2022.
- Zephyr AI, Inc. raised $18M on April 4, 2022.
- Zephyr AI, Inc. raised $19M (Seed) on March 30, 2022.
Who to call at Sherlock Biosciences, and when
A new round usually means Sherlock Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sherlock Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sherlock Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sherlock Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sherlock Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansSherlock Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.